Clinical Research Single Topic Conference
Acetaminophen Toxicity
Saturday June 9 - Sunday June 10, 2012
Emory Conference Center Hotel – Atlanta, GA
Course Directors
Richard C. Dart, MD, PhD, Paul B. Watkins, MD, and Julia Wendon, MbChB, FRCP
Course Coordinator: Eric Lavonas, MD, FACEP, FACMT
Description
Acetaminophen is both the most commonly consumed medication and the most common cause of drug-induced acute liver failure (ALF) in the developed world. Recent advances in understanding of the mechanisms underlying acetaminophen liver injury have important therapeutic implications. This 1.5-day seminar will explore the current understanding of acetaminophen toxicity, from bench to bedside, with the goal of defining better ways to prevent, treat, and rescue patients from severe acetaminophen toxicity.
The course begins on Saturday afternoon with a combined session with the Basic Science Single Topic Conference on Mitochondria in Liver Disease, and continues to explore our deepening understanding of the molecular events that manifest themselves as acetaminophen-induced acute liver injury. Sunday's clinical lectures explore the state of the art in the prevention and treatment of severe acetaminophen poisoning, including treatment strategies that are just over the translational sciences horizon.
This course is designed to be interactive. The Course Directors have chosen speakers whose cutting-edge research is shaping the therapies of tomorrow. Lectures will be highly focused, with ample opportunity to ask questions and interact with the speakers and other course participants.
Goals and Objectives
- Describe the current state of knowledge about the mechanisms of acetaminophen toxicity, with particular attention to recent advances in molecular science
- Understand and be able to apply advanced techniques in the diagnosis and management of acetaminophen-induced liver injury
- Understand the evidence underlying current strategies to prevent unintentional acetaminophen-induced liver injury
Call for Abstracts
We are no longer accepting abstract submissions.